Literature DB >> 7344109

Treatment of Opisthorchis viverrini with mebendazole.

N Jaroonvesama, K Charoenlarp, J H Cross.   

Abstract

Thirty-six hospitalized Thais (21 males, 15 females, 9 to 63 years of age) with Opisthorchis viverrini infection were treated with mebendazole in dosages of 20 mg/kg body weight for 4 weeks and 30 mg/kg body weight for 3 or 4 weeks. The drug was found to be effective when given in dosages of 30 mg/kg body weight for 3 to 4 weeks only a few eggs being found in the stool of one of 27 persons at 3 or 4 weeks post-treatment. In follow-up examination at 6 months, only two of 15 persons available were positive. These could have been reinfection, however. Side effects were essentially absent, except one person who vomited on the first day of treatment. The drug could be used in a mass treatment campaign because of effectiveness, low toxicity, and action against other helminthic infections.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7344109

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  4 in total

1.  Update on Hepatobiliary and Pulmonary Flukes.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.725

2.  Biliary parasites: diagnostic and therapeutic strategies.

Authors:  Niraj Khandelwal; Joanna Shaw; Mamta K Jain
Journal:  Curr Treat Options Gastroenterol       Date:  2008-04

3.  Low efficacy of single-dose albendazole and mebendazole against hookworm and effect on concomitant helminth infection in Lao PDR.

Authors:  Phonepasong Ayé Soukhathammavong; Somphou Sayasone; Khampheng Phongluxa; Vilavanh Xayaseng; Jürg Utzinger; Penelope Vounatsou; Christoph Hatz; Kongsap Akkhavong; Jennifer Keiser; Peter Odermatt
Journal:  PLoS Negl Trop Dis       Date:  2012-01-03

4.  Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update.

Authors:  Jong-Yil Chai; Bong-Kwang Jung; Sung-Jong Hong
Journal:  Korean J Parasitol       Date:  2021-06-21       Impact factor: 1.341

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.